https://www.selleckchem.com/pr....oducts/bay-1217389.h
The metabolomic and proteomic basis of mild cognitive impairment (MCI) and Alzheimer's disease (AD) is poorly understood and the relationships between systemic abnormalities in metabolism and AD/AMCI pathogenesis are unclear. The aim of the study was to compare the metabolomic and proteomic signature of saliva from cognitively normal and patients diagnosed with MCI or AD, to identify specific cellular pathways altered with the progression of the disease. We analyzed 80 saliva samples from individuals with MCI or AD as well as age- a
Like
Comment
Share
